DIABLO and B-cell chronic lymphocytic leukemia: 28, 29 Also, single agent activities of IAP inhibitors and small-molecule SMAC-mimetics have been reported for several tumor cell lines, and some primary tumor samples including AML and CLL.30, 31 However, the spectrum of activity of SMAC-mimetics in ALL has not been examined in detail so far.